(Pictured Left to right) Angel Padilla, Administrator, Doheny Eye Center UCLA, UCLA Department of Ophthalmology; Alfredo A. Sadun, MD, PhD, Vice Chair, Doheny Eye Center UCLA, UCLA Department of Ophthalmology; Bartly J. Mondino, MD, Distinguished Professor of Ophthalmology, UCLA Department of Ophthalmology; Anne L. Coleman, MD, PhD, Chair and Executive Medical Director, UCLA Department of Ophthalmology; Marissa Goldberg, Chief Executive Officer, Doheny Eye Institute; Vikas Chopra, MD, Medical Director, Doheny Eye Center UCLA Pasadena, UCLA Department of Ophthalmology;Anthony J. Aldave, MD, Vice Chair of Academics, UCLA Department of Ophthalmology. [Courtesy photo]
Ophthalmologists from Doheny Eye Center will provide adults and children with a variety of specialty and general ophthalmology services, including care for corneal and retinal eye diseases, glaucoma and eye infections at the expanded clinic location. Advanced testing and treatment modalities are also available onsite.
Scientists from the Doheny Eye Institute do cutting-edge ophthalmologic research on the upper floors of the building.
The clinic’s new home features 36 exam lanes, procedure rooms, laser and injection facilities, and a dedicated pediatric ophthalmology suite. The expanded facility integrates advanced diagnostic and treatment technologies with clinical research capabilities.
The relocation marks an important milestone for vision care in Southern California. Pasadena Mayor Victor Gordo strongly supported the Institute’s move to the city.
The 123,200-square-foot headquarters building, originally designed by William L. Pereira & Associates and previously serving as Avery Dennison’s headquarters, officially opened in June 2022. The seven-acre campus near the Norton Simon Museum includes 25,000 square feet of research space and a state-of-the-art conference center.
The Doheny Eye Institute, a nonprofit organization with a 75-year history in vision science, has been affiliated with UCLA Stein Eye Institute since 2013. The partnership combines expertise to advance treatments for conditions including glaucoma, macular degeneration and retinal diseases.
The Institute’s research has global impact, contributing to innovations in eye imaging and cell replacement therapies, officials said.
For more visit www.uclahealth.org/doheny-eye-center-ucla-pasadena
